CXOToday Interview on PFAS Regulations
Explore how evolving PFAS regulations are driving innovation in the medical device industry, prompting a shift towards safer material alternatives without compromising device quality.
Read ArticleCOO Compliance and Advisory
Global medical device supply chains are becoming increasingly complex, making accurate Country of Origin (COO) determination critical for ensuring trade compliance, product traceability, and uninterrupted market access. Evolving customs regulations, trade agreements, and labeling requirements demands consistent COO declarations across enterprise systems, supplier documentation, regulatory records, and product labels. Manufacturers face challenges in determining COO across multi-country manufacturing operations, reconciling inconsistent data across ERP, PLM, and supplier systems, managing documentation gaps, and maintaining compliance amid evolving regulatory requirements.
These complexities increase the risk of customs delays, incorrect tariff applications, market access restrictions, and costly remediation efforts. Tata Elxsi addresses these challenges through end-to-end Country of Origin Compliance & Advisory services that establish a structured approach to verify, correct, and standardize COO information across product labels, regulatory records, supplier documentation, and enterprise systems. By creating a single source of truth for COO data, we help organizations reduce compliance gaps, strengthen traceability, mitigate customs and supply chain risks, and build scalable governance for sustained global compliance.
Here's How We Help?
Accurate Country of Origin Determination & Compliance
- Determine and validate Country of Origin based on substantial transformation principles, applicable trade regulations, and market-specific requirements.
- Assess regulatory and business impacts, identify compliance gaps, and prepare audit-ready documentation to support global compliance.
Enterprise Data Reconciliation & Supplier Collaboration
- Reconcile COO information across ERP, SAP, PLM, labeling systems, regulatory records, and supplier documentation to establish a single source of truth.
- Engage suppliers to collect and validate declarations, resolve documentation gaps, and improve traceability across the supply chain.
Governance, Remediation & Continuous Compliance
- Execute remediation programs, manage labeling and documentation updates, and integrate COO workflows into Quality Management Systems.
- Establish governance frameworks, cross-functional collaboration, AI-enabled automation, and continuous monitoring to sustain long-term compliance and market access.
COO Intelligence & Market Access Advisory
- Develop proactive COO strategies, optimize Free Trade Agreement (FTA) opportunities, and assess geopolitical and regulatory risks.
- Enable ongoing compliance monitoring, regulatory intelligence, and market access readiness across global markets.
Our Country of Origin (COO) Determination & Remediation Framework
Tata Elxsi's Country of Origin (COO) Determination & Remediation Framework provides a structured approach to accurately determine, validate, and maintain COO compliance across global product portfolios. Combining regulatory expertise, enterprise-wide data reconciliation, supplier collaboration, and AI-enabled intelligence, the framework helps organizations establish a single source of truth for COO information, accelerate remediation programs, strengthen governance, and maintain audit-ready compliance across evolving global trade and regulatory landscapes.
Assess & Align
Establish the foundation for Country of Origin compliance by defining program scope, identifying applicable trade and regulatory requirements, and assessing business impact. Enterprise data is collected from ERP, SAP, PLM, labeling systems, and supplier records to identify inconsistencies, documentation gaps, and remediation priorities.
Determine & Validate
Tata Elxsi's AI-enabled Country of Origin determination methodology accelerates large-scale compliance programs through a structured five-step approach that analyzes intended product purpose, identifies major components, evaluates substantial transformation, determines the region of transformation, and generates analyst-reviewed Country of Origin determinations supported by confidence scoring, CBP references, and complete audit trails.
Remediate & Govern
Execute remediation through supplier engagement, documentation updates, labeling changes, and cross-functional collaboration. Standardized governance frameworks, Quality Management System integration, continuous monitoring, and AI-enabled compliance intelligence help sustain long-term Country of Origin compliance and support seamless global market access.
Why Tata Elxsi?
- Proven experience delivering high-volume Country of Origin determination, validation, and remediation programs across global product portfolios.
- AI-enabled 5-step COO determination methodology delivering up to 6× faster execution, 59% lower remediation effort, and 100% audit-ready evidence packages.
- End-to-end capabilities spanning regulatory assessment, enterprise data reconciliation, supplier engagement, remediation, governance, and market access advisory.
- Expertise across SAP, ERP, PLM, MES, labeling, and supplier ecosystems to establish a trusted source of COO data.
Information Hub
-
Why is Country of Origin compliance critical for medical device OEMs?
Country of Origin is no longer simply a label on a box, it is a foundational compliance requirement that impacts customs duty rate, and eligibility for market access across every country it enters. Regulatory and Custom authorities worldwide require accurate, documented COO as part of product labelling and import clearance. A single COO discrepancy across systems or documentation leads to import delays, compliance issues, penalties, and increased costs.
-
What are the key trends shaping COO compliance in medical devices today?
Rising global tariffs, stricter regulatory scrutiny under EU MDR/IVDR, and increasing supply chain complexity are making COO compliance more important than ever. Mergers and acquisitions are also exposing hidden COO risks in product portfolios. Together, these trends mean that OEMs without a structured, auditable COO program face growing exposure across every dimension be it regulatory, financial, and commercial.
-
How does accurate COO determination support faster market access and product approvals?
Accurate COO determination is a prerequisite, not an afterthought for smooth custom clearance and uninterrupted market access. Consistent COO information across documentation reduces the likelihood of deficiency letters, shipment holds, and import delays, ensuring supply continuity from day one of commercial launch.
-
What are the business consequences of COO non-compliance and how significant is the financial exposure?
COO non-compliance can result in customs penalties, import detentions, regulatory deficiencies, and delayed market access. It may also trigger retroactive duty assessments and supply chain disruptions. Beyond direct financial losses, non-compliance can negatively impact profitability, business continuity, and customer confidence. In today's tariff environment, COO accuracy is a direct determinant of product line profitability.
-
What role does data reconciliation play in COO determination and why do most OEMs struggle with it?
COO determination relies on consistent data across ERP, PLM, MES, labelling, and other systems. Many OEMs struggle because origin information is often fragmented, outdated, or inconsistent across these platforms. Data reconciliation helps establish a single, accurate source of truth and supports defensible COO decisions.
-
Can COO determination and remediation be outsourced? What are the benefits?
Yes, COO determination and remediation can be effectively outsourced to specialized service provider with expertise in both medical device regulatory requirements and global trade requirements. This allows internal teams to focus to stay focused on product development and commercial priorities while reducing compliance risk and operational burden.
